Use of cefoperazone MacConkey agar for selective isolation of Laribacter hongkongensis.
A new selective medium, cefoperazone MacConkey agar (CMA), was developed for primary isolation of Laribacter hongkongensis from stool. Its performance in quantitative recovery and in a clinical evaluation of 4,741 human diarrheal stool specimens was superior to that of charcoal cefoperazone deoxycholate agar. In addition, with CMA, Arcobacter butzleri was unexpectedly isolated from the stools of six patients.
Lau
Susanna K P
SK
Department of Microbiology, The University of Hong Kong, Hong Kong.
Woo
Patrick C Y
PC
Hui
Wai-ting
WT
Li
Maria W S
MW
Teng
Jade L L
JL
Que
Tak-Lun
TL
Luk
Wei-Kwang
WK
Lai
Raymond W M
RW
Yung
Raymond W H
RW
Yuen
Kwok-yung
KY
D000362:Agar; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001431:Bacteriological Techniques; D002438:Cefoperazone / Q000494:pharmacology*; D003470:Culture Media; D003967:Diarrhea / Q000382:microbiology; D005243:Feces / Q000382:microbiology; D016905:Gram-Negative Bacterial Infections / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009346:Neisseriaceae / Q000187:drug effects / Q000254:growth & development* / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D003470:Culture Media; D002438:Cefoperazone; D000362:Agar